Healthequity (HQY) Depreciation & Amortization (CF) (2013 - 2026)

Healthequity's Depreciation & Amortization (CF) history runs 14 years deep, the most recent figure standing at $38.2 million for Q2 2026.

• In Q2 2026, Depreciation & Amortization (CF) fell 1.36% year-over-year to $38.2 million; the TTM figure through Apr 2026 stood at $154.1 million (down 5.01% YoY), while the FY2026 annual figure was $154.7 million, down 4.8% from the prior year.
• Depreciation & Amortization (CF) was $38.2 million for Q2 2026 at Healthequity, down from $38.7 million in the prior quarter.
• In the past five years, Depreciation & Amortization (CF) ranged from a high of $43.6 million in Q3 2024 to a low of $37.8 million in Q4 2023.
• Historically, Depreciation & Amortization (CF) has averaged $39.4 million across 5 years, with a median of $38.9 million in 2022.
• The sharpest annual moves came in 2022 and 2025: Depreciation & Amortization (CF) climbed 27.63% in 2022, then fell 11.82% in 2025.
• A 5-year view of Depreciation & Amortization (CF) shows it stood at $40.5 million in 2022, then fell by 6.72% to $37.8 million in 2023, then advanced by 7.78% to $40.7 million in 2024, then declined by 4.77% to $38.8 million in 2025, then retreated by 1.46% to $38.2 million in 2026.
• The last three Depreciation & Amortization (CF) figures came in at $38.2 million (Q2 2026), $38.7 million (Q1 2026), and $38.8 million (Q4 2025), per Business Quant data.